Literature DB >> 31708148

National Burden Estimates of healthy life lost in India, 2017: an analysis using direct mortality data and indirect disability data.

Geetha R Menon1, Lucky Singh2, Palak Sharma2, Priyanka Yadav2, Shweta Sharma2, Shrikant Kalaskar2, Harpreet Singh2, Srividya Adinarayanan2, Vasna Joshua2, Vaitheeswaran Kulothungan2, Jeetendra Yadav2, Leah K Watson3, Shaza A Fadel3, Wilson Suraweera3, M Vishnu Vardhana Rao2, R S Dhaliwal2, Rehana Begum3, Prabha Sati3, Dean T Jamison4, Prabhat Jha5.   

Abstract

BACKGROUND: Many countries, including India, seek locally constructed disease burden estimates comprising mortality and loss of health to aid priority setting for the prevention and treatment of diseases. We created the National Burden Estimates (NBE) to provide transparent and understandable disease burdens at the national and subnational levels, and to identify gaps in knowledge.
METHODS: To calculate the NBE for India, we combined 2017 UN death totals with national and subnational mortality rates for 2010-17 and causes of death from 211 166 verbal autopsy interviews in the Indian Million Death Study for 2010-14. We calculated years of life lost (YLLs) and years lived with disability (YLDs) for 2017 using published YLD-YLL ratios from WHO Global Health Estimates. We grouped causes of death into 45 groups, including ill-defined deaths, and summed YLLs and YLDs to calculate disability-adjusted life-years (DALYs) for these causes in eight age groups covering rural and urban areas and 21 major states of India.
FINDINGS: In 2017, there were about 9·7 million deaths and 486 million DALYs in India. About three quarters of deaths and DALYs occurred in rural areas. More than a third of national DALYs arose from communicable, maternal, perinatal, and nutritional disorders. DALY rates in rural areas were at least twice those of urban areas for perinatal and nutritional conditions, chronic respiratory diseases, diarrhoea, and fever of unknown origin. DALY rates for ischaemic heart disease were greater in urban areas. Injuries caused 11·4% of DALYs nationally. The top 15 conditions that accounted for the most DALYs were mostly those causing mortality (ischaemic heart disease, perinatal conditions, chronic respiratory diseases, diarrhoea, respiratory infections, cancer, stroke, road traffic accidents, tuberculosis, and liver and alcohol-related conditions), with disability mostly due to a few conditions (nutritional deficiencies, neuropsychiatric conditions, vision and other sensory loss, musculoskeletal disorders, and genitourinary diseases). Every condition that was common in one part of India was uncommon elsewhere, suggesting state-specific priorities for disease control.
INTERPRETATION: The NBE method quantifies disease burden using transparent, intuitive, and reproducible methods. It provides a simple, locally operable tool to aid policy makers in priority setting in India and other low-income and middle-income countries. The NBE underlines the need for many more countries to collect nationally representative cause of death data, paired with focused surveys of disability. FUNDING: Ministry of Health and Family Welfare, Government of India.
Copyright © 2019 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Mesh:

Year:  2019        PMID: 31708148     DOI: 10.1016/S2214-109X(19)30451-6

Source DB:  PubMed          Journal:  Lancet Glob Health        ISSN: 2214-109X            Impact factor:   26.763


  20 in total

1.  The hazards of smoking and the benefits of cessation: a critical summation of the epidemiological evidence in high-income countries.

Authors:  Prabhat Jha
Journal:  Elife       Date:  2020-03-24       Impact factor: 8.140

2.  Trends in snakebite deaths in India from 2000 to 2019 in a nationally representative mortality study.

Authors:  Wilson Suraweera; David Warrell; Romulus Whitaker; Geetha Menon; Rashmi Rodrigues; Sze Hang Fu; Rehana Begum; Prabha Sati; Kapila Piyasena; Mehak Bhatia; Patrick Brown; Prabhat Jha
Journal:  Elife       Date:  2020-07-07       Impact factor: 8.140

Review 3.  Potential for establishing an injury surveillance system in India: a review of data sources and reporting systems.

Authors:  Jagnoor Jagnoor; Manickam Ponnaiah; Matthew Varghese; Rebecca Ivers; Rajesh Kumar; Shankar Prinja; Aliki Christou; Tanu Jain
Journal:  BMC Public Health       Date:  2020-12-14       Impact factor: 3.295

4.  The Health Impact Fund: making the case for engagement with pharmaceutical laboratories in Brazil, Russia, India, and China.

Authors:  Vivian Chia-Jou Lee; Jacqueline Yao; William Zhang
Journal:  Global Health       Date:  2021-09-06       Impact factor: 4.185

Review 5.  Reducing the Global Burden of Alcohol-Associated Liver Disease: A Blueprint for Action.

Authors:  Sumeet K Asrani; Jessica Mellinger; Juan P Arab; Vijay H Shah
Journal:  Hepatology       Date:  2021-05       Impact factor: 17.298

6.  The civil registration system is a potentially viable data source for reliable subnational mortality measurement in India.

Authors:  Chalapati Rao; Mamta Gupta
Journal:  BMJ Glob Health       Date:  2020-08

7.  Opportunities for the development of drowning interventions in West Bengal, India: a review of policy and government programs.

Authors:  M Gupta; A B Zwi; J Jagnoor
Journal:  BMC Public Health       Date:  2020-05-15       Impact factor: 3.295

8.  Road Use Pattern and Street Crossing Habits of Schoolchildren in India.

Authors:  Rajnarayan R Tiwari; Shruti Patel; Annie Soju; Prarthana Trivedi
Journal:  Front Public Health       Date:  2021-02-05

Review 9.  The Role of Micronutrients in Ageing Asia: What Can Be Implemented with the Existing Insights.

Authors:  Taichi Inui; Bryan Hanley; E Siong Tee; Jun Nishihira; Kraisid Tontisirin; Peter Van Dael; Manfred Eggersdorfer
Journal:  Nutrients       Date:  2021-06-29       Impact factor: 5.717

10.  All-cause mortality during the COVID-19 pandemic in Chennai, India: an observational study.

Authors:  Joseph A Lewnard; Ayesha Mahmud; Tejas Narayan; Brian Wahl; T S Selvavinayagam; Chandra Mohan B; Ramanan Laxminarayan
Journal:  Lancet Infect Dis       Date:  2021-12-22       Impact factor: 71.421

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.